David Shaw’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-125,020
Closed -$241K 4583
2023
Q2
$241K Buy
125,020
+102,680
+460% +$177K ﹤0.01% 3676
2023
Q1
$18.1K Buy
+22,340
New +$32.6K ﹤0.01% 4158
2022
Q4
Sell
-20,391
Closed -$32K 5239
2022
Q3
$32K Sell
20,391
-71,130
-78% -$162K ﹤0.01% 4750
2022
Q2
$162K Sell
91,521
-49,325
-35% -$125K ﹤0.01% 4614
2022
Q1
$585K Sell
140,846
-112,929
-44% -$379K ﹤0.01% 4278
2021
Q4
$644K Sell
253,775
-181,593
-42% -$598K ﹤0.01% 4254
2021
Q3
$1.71M Buy
435,368
+295,928
+212% +$1.48M ﹤0.01% 3180
2021
Q2
$894K Buy
+139,440
New +$961K ﹤0.01% 3632

Other funds holding GMDA

David Shaw's GMDA Position: Q3 2023 in Review

David Shaw sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q3 2023, closing a stake of 125,020 shares — an estimated $241K sold.

David Shaw first reported a position in GMDA in Q2 2021 and held it in 8 quarters. The position peaked at $1.71M in Q3 2021. 60 funds tracked by Wall St. Rank hold GMDA as of Q3 2023.

  • David Shaw reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • David Shaw sold 125,020 Gamida Cell Ltd. Ordinary Shares shares in Q3 2023, an estimated $241K.
  • David Shaw first reported a position in Gamida Cell Ltd. Ordinary Shares in Q2 2021 and held it in 8 quarters.
  • David Shaw's Gamida Cell Ltd. Ordinary Shares position peaked at $1.71M in Q3 2021.
  • 60 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q3 2023.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.